The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
FDA grants accelerated approval to epcoritamab-bysp for relapsed or refractory follicular lymphoma
On June 26, 2024, the Food and Drug Administration granted accelerated approval to epcoritamab-bysp, a…